US2023232793A1PendingUtilityA1
Method for producing an animal comprising a germline genetic modification
Est. expiryAug 7, 2035(~9 yrs left)· nominal 20-yr term from priority
A01K 67/0275C12N 15/90C12N 9/22C12N 15/88A01K 2217/072A01K 2227/30A01K 2267/02C12N 2310/20C07H 21/02
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for producing a non-human animal, such as an avian, comprising a targeted germline genetic modification, the method comprising: (i) delivering a programmable nuclease to sperm; (ii) fertilizing an ovum with the sperm, and (iii) generating the animal from the ovum, wherein the nuvlease introduces the genetic modification into DNA of the prem and/or the ovum.
Claims
exact text as granted — not AI-modified1 . A method for producing a non-human animal comprising a targeted germline genetic modification, the method comprising:
(i) delivering a programmable nuclease to sperm; (ii) fertilizing an ovum with the sperm, and (iii) generating the animal from the ovum,
wherein the nuclease introduces the genetic modification into DNA of the sperm and/or the ovum.
2 . The method of claim 1 which further comprises screening the animal obtained from step (iii) for the germline genetic modification.
3 . The method of claim 1 or claim 2 , wherein the nuclease is delivered to the sperm in a composition comprising a transfection agent.
4 . The method according to any one of claims 1 to 3 , wherein the nuclease is selected from a: RNA-guided engineered nuclease (RGEN), transcription activator-like nuclease (TALEN) and zinc-finger nuclease (ZFN).
5 . The method of claim 4 , wherein the nuclease is a RNA-guided engineered nuclease (RGEN).
6 . The method according to any one of claims 2 to 5 , wherein the transfection agent comprises a cationic lipid.
7 . The method of claim 6 , wherein the transfection agent comprises a monovalent cationic lipid selected from one or more of DOTMA (N-[1-(2.3-dioleoyloxy)-propyl]-N,N,N-trimethyl ammonium chloride), DOTAP (1,2-bis(oleoyloxy)-3-3-(trimethylammonium)propane), DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bromide) and DDAB (dimethyl dioctadecyl ammonium bromide).
8 . The method of claim 6 or claim 7 , wherein the transfection agent comprises a polyvalent cationic lipid selected from one or more of DOSPA (2,3-dioleyloxy-N-[2(sperminecarboxamido)ethyl]-N,N-dimethyl-1-propanaminium trifluoroacetate) and DOSPER (1,3-dioleoyloxy-2-(6carboxy spermyl)-propyl-amid, TMTPS (tetramethyltetrapalmitoylspermine), TMTOS (tetramethyltetraoleylspermine), TMTLS (tetramethlytetralaurylspermine), TMTMS (tetramethyltetramyristylspermine) and TMDOS (tetramethyldioleylspermine).
9 . The method according to any one of claims 1 to 8 , wherein the genetic modification results in reduced expression of one or more genes and/or proteins in the animal and/or progeny thereof.
10 . The method according to any one of claims 1 to 9 , wherein the genetic modification is a deletion, substitution or an insertion.
11 . The method of claim 10 , wherein the insertion is a transgene.
12 . The method according to any one of claims 1 to 11 , wherein step (ii) comprises artificially inseminating the sperm into a female animal.
13 . The method according to any one of claims 1 to 12 , wherein at least 10% of the animals produced using the method comprise the targeted germline genetic modification.
14 . The method according to any one of claims 1 to 13 , wherein all cells of the animal comprise the targeted germline genetic modification.
15 . The method according to any one of claims 1 to 14 , wherein the animal is heterozygous for the targeted germline genetic modification.
16 . The method according to any one of claims 1 to 15 , wherein the targeted germline genetic modification modifies a trait of the animal.
17 . The method according to any one claims 1 to 16 , wherein the animal is an avian.
18 . The method of claim 17 , wherein the avian is selected from a chicken, duck, turkey, goose, bantam or quail.
19 . An animal produced by the method of any one of claims 1 to 18 , or progeny thereof.
20 . Sperm or an ovum produced by the animal of claim 19 .
21 . A method for producing a genetically modified animal, the method comprising:
(i) crossing a first animal of claim 19 with a second animal of the same species, and (ii) selecting progeny comprising the targeted germline genetic modification.
22 . The method of claim 21 which comprises selecting progeny which are homozygous for the targeted germline genetic modification.
23 . The method of claim 22 , wherein the first and second animal are heterozygous for the targeted germline genetic modification.
24 . An animal produced by the method according to any one of claims 21 to 23 .
25 . A method of producing food, the method comprising:
(i) obtaining the animal of claim 19 or claim 24 , and (ii) producing food from the animal.
26 . The method of claim 25 , wherein the method comprises harvesting meat and/or eggs from the animal.Join the waitlist — get patent alerts
Track US2023232793A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.